News
Nokia’s dive into the digital health industry may be coming to a halt, reveals a memo leaked to The Verge earlier this week.
Integration of a practitioner-developed mobile health system within a primary care setting was well-received by substance use disorder (SUD) patients and generally improved outcomes, according to a study recently published in the Journal of Medical Internet Research.
Implantable glucose sensor company Senseonics has launched a remote monitoring app for its users in Europe, the Middle East, and Africa, where its CGM system is distributed by Roche.
About the author: Naomi Fried, PhD, is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation-program design and optimization consulting to healthcare stakeholders including pharma, payers, and providers.
This morning San Luis Obispo-based wellness platform Mindbody announced the acquisition of FitMetrix, a performance tracking engagement platform, for an undisclosed sum.
Palo Alto, California-based Cognoa’s machine learning app for pediatric behavioral health has received categorization from the FDA as a diagnostic medical device for autism, according to an announcement from the company.
New York and Palo Alto, California-based MemoryMD has received FDA clearance for NeuroEEG, a wireless amplifier that transmits EEG signals to computers and cloud-based databases via Bluetooth.
Roche’s Accu-Chek Connect Diabetes Management App has hit yet another snag with the FDA.
Optra Health, which produces AI-driven iPhronesis analysis platform for healthcare and life sciences clients, today announced the launch of a new genetics-focused product specially designed for consumers, genetic counselors, and other genomics researchers.
The University of Pennsylvania's Penn Medicine has been an active player in the telehealth game for sometime with multiple telehealth units, but last week it went a step further to announce that it will be centralizing its telemedicine activities into the Penn Medicine Center for Connected Care.